Results for the Future of HCV Treatment (10/21/06) Survey
Was VRTX a choice in this survey regarding who might be a current investor? With future HCV treatments "most likely" being a cocktail of the different drug classes, I continue to be fascinated as to why investors continue to value VRTX so much. A single therapy drug is very unlikely (IMHO).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.